fecal microbiota
A Miss for FMT in Ulcerative Colitis, Additional Upadacitinib Benefits in Crohn’s
This month’s report looks at two distinct issues: fecal microbiota transplantation and upadacitinib.
SEPTEMBER 17, 2024
A New Era for Managing Clostridioides difficile Infection
We have started to understand the critical components of the gut microbiome that prevent C. difficile expansion, ...
OCTOBER 17, 2023
FDA Approves First Orally Administered Fecal Microbiota Product to Prevent C. diff Recurrence
The FDA approved the first fecal microbiota product that is taken orally to prevent recurrent CDI in people who are ...
APRIL 28, 2023
FDA Approves Rebyota, the First Live Biotherapeutic Fecal Microbiota Product in the U.S.
RBX2660 (Rebyota, Ferring) is approved by the FDA for the prevention of recurrent Clostridioides difficile ...
DECEMBER 5, 2022
Load more